Loading...
XNAS
XWEL
Market cap65mUSD
Dec 05, Last price  
0.79USD
1D
1.79%
1Q
-27.72%
IPO
-99.90%
Name

XWELL Inc

Chart & Performance

D1W1MN
XNAS:XWEL chart
P/E
—
P/S
1.94
EPS
—
Div Yield, %
—
Shrs. gr., 5y
124.02%
Rev. gr., 5y
-6.92%
Revenues
34m
+12.58%
020,000211,000718,000369,0001,100,0001,425,00022,687,00018,974,00048,823,00050,094,00048,515,0008,385,00073,729,00055,939,00030,109,00033,897,000
Net income
-17m
L-39.25%
-7,332,000-6,149,000-9,942,000-7,479,000-20,841,000-52,433,000-109,677,000-11,157,000-24,006,000-28,840,000-37,205,000-20,530,000-92,232,0003,349,000-32,629,000-27,741,000-16,853,000
CFO
-11m
L-31.54%
-7,296,000-4,850,000-6,361,000-5,380,000-14,468,000-23,465,000-28,382,000-2,571,000-8,441,000-12,172,000-6,566,000-113,000-25,012,00015,642,000-24,188,000-16,074,000-11,005,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
URL
https://www.xwell.com/
IPO date
Jun 18, 2010
Employees
363
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT